Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Reactive arthritis].

Sylvie Revaz1, Jean Dudler

  • 1Service de rhumatologie, médecine physique et réhabilitation, CHUV, 1011 Lausanne. Sylvie.Revaz@chuv.ch

Revue Medicale Suisse
|April 12, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Biological treatments for rheumatology : specific situations and risks].

Revue medicale suisse·2026
Same author

Sleep improvement in patients with rheumatoid arthritis treated with upadacitinib in real-world practice: results from the SLEERA study.

Arthritis research & therapy·2026
Same author

[Rheumatology : what's new in 2025].

Revue medicale suisse·2026
Same author

Identification of individuals at high risk of developing rheumatoid arthritis: a balanced random forest model in a cohort of 1544 first-degree relatives.

RMD open·2025
Same author

[Biological treatments for rheumatology : demystifying the risks].

Revue medicale suisse·2025
Same author

BASDAI and ASDAS disease states in relationship to ASAS40 response: post hoc analysis of ixekizumab in radiographic axial spondyloarthritis.

Rheumatology advances in practice·2025

Reactive arthritis, linked to HLA-B27, causes joint inflammation after infection. While generally manageable, HLA-B27 positive patients may benefit from a prolonged antibiotic course, pending further research.

Area of Science:

  • Rheumatology and Immunology
  • Infectious Diseases

Context:

  • Reactive arthritis is a systemic autoimmune disease.
  • It is strongly associated with the human leukocyte antigen B27 (HLA-B27) gene.
  • Characterized by sterile joint inflammation following an infection.

Purpose:

  • To outline the clinical features, diagnosis, and management of reactive arthritis.
  • To discuss the role of HLA-B27 in disease prognosis and recurrence.
  • To evaluate the potential long-term benefits of antibiotic therapy.

Summary:

  • Diagnosis relies on patient history, clinical evaluation, and serological tests.
  • Prognosis is typically favorable, though recurrences are common, especially in HLA-B27 positive individuals.
  • Symptomatic treatment is primary; antibiotics are reserved for active infections, with a potential long-term benefit in HLA-B27 positive patients requiring further study.

Related Experiment Videos

Impact:

  • Informs clinical practice regarding the diagnosis and management of reactive arthritis.
  • Highlights the prognostic significance of HLA-B27 status.
  • Suggests a potential therapeutic avenue for HLA-B27 positive patients that warrants further investigation.